Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    FirstTest

    April 2017 - The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.

    Over five years the iCMLf have awarded 42 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2017 the Foundation will again offer 10 grants with funding of up to $10,000.

    Applications will close on the 30th of June 2017. Proposals are welcome to melissa@cml-foundation.org or read more for further information on how to apply.

    'This is the first CML-related molecular assay in Ethiopia. We are extremely glad to know the molecular status of our patients. No more blind treatment of CML patients in Ethiopia'
    (Dr Gebremedhin, Ethiopia)

    Through the Diagnosis and Testing grants the iCMLf assists centres in the emerging economic regions to enhance facilities at a local level to either, bring high quality testing to the patient, or to develop a low cost strategy for sending patient samples to a central reference laboratory for testing. Developing local diagnostic capacity and resource sustainability are important criteria for these grants.

    Previous projects have involved the purchase of equipment and reagents, staff training, education events and resource, sample shipments and patient education.

    Institutions awarded grants will partner with a CML centre of excellence to ensure the successful implementation of the proposal and to offer ongoing mentoring and support at a clinical and laboratory level.

    Full application and eligibility criteria for the grants can be found on the program information here:

    Along with the application form here:

    All questions and submissions should be addressed to: melissa@cml-foundation.org. Applications will close on the 30th of June 2017. The selection of 2017 grants will be held in July.